Influence of Bag Volume Variation on the Reproducibility of Inert Gas Rebreathing
NCT ID: NCT01762917
Last Updated: 2013-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2007-09-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Accuracy of Non-invasive Continuous CO2-Monitoring
NCT00247949
Mathematical Arterialisation of Capillary Blood for Blood Gas Analysis in Critical Ill Patients
NCT04144296
Non-Invasive Determination of Cardiac Output by Inertgas Rebreathing Method
NCT00479804
The Utility of Regional Bioimpedance in Chronically Ventilated Patients
NCT02951936
Cardiopulmonary Response to Conical-PEP Breathing During Exercise in Older People.
NCT02788370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Obstruction
Patients suffering from pulmonary obstruction
No interventions assigned to this group
Restriction
Patients suffering from pulmonary restriction
No interventions assigned to this group
Controls
Pulmonary healthy controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsmedizin Mannheim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joachim Saur
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Mannheim
Mannheim, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IGR_Vbag_MA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.